Multisource drugs: implications and concerns in the geriatric population

Area of Science:

• Pharmaceutical Sciences
• Gerontology
• Health Economics

Background:

• Increasing healthcare costs and drug benefit restrictions drive demand for cost-effective pharmaceuticals.
• Patent expirations and evolving patient demographics enhance the availability and need for multisource drugs.
• Regulatory focus on the Food and Drug Administration (FDA) and Abbreviated New Drug Application (ANDA) processes supports the multisource industry.

Purpose of the Study:

• To review concerns and issues regarding the use of multisource drugs in the elderly population.
• To place into perspective the role of multisource pharmaceuticals for elderly patients.
• To address the growing need for affordable medications among older adults.

Main Methods:

• Literature review of existing studies and regulatory information.
• Analysis of pharmaceutical market trends and demographic data.
• Examination of safety and efficacy data for multisource drugs in geriatric populations.

Main Results:

• Multisource drugs provide significant cost savings, crucial for the elderly.
• While generally safe, specific concerns exist regarding multisource drug use in the elderly.
• Regulatory oversight ensures quality and integrity in the multisource drug approval process.

Conclusions:

• Multisource pharmaceuticals play a vital role in providing affordable healthcare to the elderly.
• Addressing specific concerns is essential for optimizing the use of multisource drugs in this demographic.
• Continued vigilance and quality assessment are paramount for multisource drug utilization.